GALECTIN THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2021 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Galectin Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q4 2024.
  • Galectin Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $16K, a 65.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $16K -$30K -65.2% Dec 31, 2024 10-K 2025-03-31
Q3 2024 $26K -$36K -58.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $35K -$35K -50% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $45K -$33K -42.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $46K -$40K -46.5% Dec 31, 2023 10-K 2025-03-31
Q3 2023 $62K -$31K -33.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $70K -$31K -30.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $78K -$30K -27.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $86K +$79K +1129% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $93K +$75K +417% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $101K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $108K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $7K Dec 31, 2021 10-K 2022-03-31
Q3 2021 $18K Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.